Xtx Topco LTD Next Cure, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.17 - $2.49 $1,396 - $2,973	1,194 Added 6.07%	20,874 $33,000
Q1 2024 May 13, 2024	BUY	$1.13 - $2.23 $2,770 - $5,467	2,452 Added 14.23%	19,680 $43,000
Q4 2023 Feb 13, 2024	BUY	$1.03 - $1.45 $17,744 - $24,980	17,228 New	17,228 $19,000
Q2 2022 Aug 15, 2022	BUY	$3.38 - $5.27 $74,120 - $115,565	21,929 New	21,929 $103,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $26.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.